folic acid has been researched along with ADPKD in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, Z; Kullak-Ublick, GA; Samodelov, SL; Visentin, M | 1 |
| Kipp, KR; Kruger, SL; Leamon, CP; Parker, N; Schimmel, MF; Shillingford, JM; Weimbs, T | 1 |
| Chung, EJ; Hallows, KR | 1 |
| Leamon, CP; Shillingford, JM; Vlahov, IR; Weimbs, T | 1 |
1 review(s) available for folic acid and ADPKD
| Article | Year |
|---|---|
Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Homeostasis; Humans; Kidney; Nutritional Status; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Renal Reabsorption; Risk Assessment; Risk Factors | 2019 |
3 other study(ies) available for folic acid and ADPKD
| Article | Year |
|---|---|
Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease.
Topics: A549 Cells; Animals; Disease Models, Animal; Drug Compounding; Folate Receptor 1; Folic Acid; Humans; Integrases; Kidney; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Signal Transduction; Sirolimus; Tissue Distribution; TOR Serine-Threonine Kinases; TRPP Cation Channels | 2018 |
"First do no harm": kidney drug targeting to avoid toxicity in ADPKD.
Topics: Animals; Drug Delivery Systems; Folic Acid; Kidney; Mice; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Sirolimus | 2018 |
Folate-conjugated rapamycin slows progression of polycystic kidney disease.
Topics: Animals; Cell Line; Disease Models, Animal; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Kidney; Mice; Polycystic Kidney, Autosomal Dominant; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2012 |